title: Cardiovascular and metabolic responses to fasting and thermoneutrality in Ay mice.
abstract: Several lines of evidence support a role for reduced melanocortin signaling in the regulation of metabolic rate and cardiovascular function during negative energy balance. We tested the hypothesis that agouti yellow (B6.Cg-A(y)) mice would exhibit blunted physiologic responses to fasting and thermoneutrality. Male B6.Cg-A(y) mice (A(y); n=11, 34+/-2 g) and lean B6 littermates (B6; n=7, 26+/-2 g) were implanted with telemetry devices and housed in metabolic chambers (T(a)=23 degrees C) to determine the effects of a 24-h fasting and exposure to thermoneutrality (T(a)=30 degrees C) on mean arterial pressure (MAP), heart rate (HR), AP and HR variability (time and frequency domain), oxygen consumption (VO(2)), and locomotor activity. A(y) mice exhibited elevated baseline light-period MAP (A(y): 113+/-4; B6: 99+/-3 mm Hg) and VO(2) (A(y): 1.82+/-0.08 vs. B6: 1.45+/-0.13 ml/min) with no difference in HR (A(y): 530+/-12 vs. B6: 548+/-19 bpm). At 12-24 h after food removal, A(y) mice displayed normal fasting-induced bradycardia (A(y): -106+/-12; B6: -117+/-19 bpm) and reduction in VO(2) (A(y): -0.19+/-0.04 vs. B6: -0.28+/-0.05 ml/min), but with augmented hypotension (A(y): -9+/-2 vs. B6: -0.5+/-2 mm Hg) and blunted hyperactivity (A(y): 27+/-23 vs. B6: 122+/-42 m/11 h). Fasting was associated with increased HR variability in both time and frequency domain in B6 but not A(y) mice. Exposure to thermoneutrality produced comparable reductions in MAP, HR, and VO(2) in both strains. We conclude that inhibition of melanocortin signaling is not requisite for, but participates in, the metabolic and cardiovascular responses to negative energy balance.
authors.affiliation: Department of Nutrition, Food, and Exercise Sciences, Florida State University, 236 Biomedical Research Facility, Tallahassee, FL 32306-4340, USA.
authors.forename: T D
authors.initials: TD
authors.lastname: Williams
authors.forename: J B
authors.initials: JB
authors.lastname: Chambers
authors.forename: S P
authors.initials: SP
authors.lastname: Gagnon
authors.forename: L M
authors.initials: LM
authors.lastname: Roberts
authors.forename: R P
authors.initials: RP
authors.lastname: Henderson
authors.forename: J M
authors.initials: JM
authors.lastname: Overton
mesh_terms: D054366:Agouti Signaling Protein; D000818:Animals; D001341:Autonomic Nervous System / Q000502:physiology; D001794:Blood Pressure / Q000235:genetics / Q000502:physiology; D001833:Body Temperature Regulation / Q000235:genetics* / Q000502:physiology*; D001835:Body Weight / Q000502:physiology; D002153:Calorimetry, Indirect; D004435:Eating / Q000502:physiology; D005215:Fasting / Q000378:metabolism / Q000502:physiology*; D006339:Heart Rate / Q000235:genetics / Q000502:physiology; D006439:Hemodynamics / Q000235:genetics* / Q000502:physiology*; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics; D008297:Male; D008660:Metabolism / Q000502:physiology*; D051379:Mice; D009043:Motor Activity / Q000502:physiology; D009154:Mutation / Q000235:genetics; D010101:Oxygen Consumption / Q000235:genetics / Q000502:physiology; D013686:Telemetry
chemical_list: D054366:Agouti Signaling Protein; D036341:Intercellular Signaling Peptides and Proteins